HIF-mediated endothelial response during cancer progression
- 8 May 2012
- journal article
- review article
- Published by Springer Nature in International Journal of Hematology
- Vol. 95 (5) , 471-477
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Endothelial HIF-2α regulates murine pathological angiogenesis and revascularization processesJournal of Clinical Investigation, 2012
- Endothelial Cell HIF-1α and HIF-2α Differentially Regulate Metastatic SuccessCancer Cell, 2012
- Macrophage Expression of Hypoxia-Inducible Factor-1α Suppresses T-Cell Function and Promotes Tumor ProgressionCancer Research, 2010
- Endothelial deletion of hypoxia-inducible factor–2α (HIF-2α) alters vascular function and tumor angiogenesisBlood, 2009
- FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?Nature Reviews Cancer, 2008
- Trousseau's syndrome: multiple definitions and multiple mechanismsBlood, 2007
- Increased Melanoma Growth and Metastasis Spreading in Mice Overexpressing Placenta Growth FactorThe American Journal of Pathology, 2006
- Signaling of the Tissue Factor Coagulation Pathway in Angiogenesis and CancerArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- The biology of VEGF and its receptorsNature Medicine, 2003
- Nitric oxide-generating vasodilators inhibit mitogenesis and proliferation of BALBc 3T3 fibroblasts by a cyclic GMP-independent mechanismBiochemical and Biophysical Research Communications, 1990